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We investigated naturally-occurring variation within the major (L1) and minor (L2)
capsid proteins of oncogenic human papillomavirus (HPV) genotype HPV31 to
determine the impact on capsid antigenicity. L1L2 pseudoviruses (PsV)
representing the three HPV31 variant lineages A, B and C exhibited comparable
particle to infectivity ratios and morphology. Lineage-specific L1L2 PsV
demonstrated subtle differences in susceptibility to neutralization by antibodies
elicited following vaccination, pre-clinical L1 VLP immunization or by monoclonal
antibodies; however, these differences were generally of a low magnitude. These
data indicate diagnostic lineage-specific single nucleotide polymorphisms within
the HPV31 capsid genes have a limited effect on L1 antibody mediated
neutralization and that the three HPV31 variant lineages belong to a single L1
serotype. These data contribute to our understanding of HPV L1 variant
antigenicity.
IMPORTANCE: The virus coat (capsid) of the human papillomavirus contains
major (L1) and minor (L2) capsid proteins. These proteins facilitate host cell
attachment and viral infectivity and are the targets for antibodies which interfere
with these events. In this study we investigated the impact of naturally-occurring
variation within these proteins upon susceptibility to viral neutralization by
antibodies induced by L1 VLP immunization. We demonstrate that HPV31 L1 and
L2 variants exhibit similar susceptibility to antibody-mediated neutralization and
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